Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience

Bibliographic Details
Main Authors: I. Vaxman, S. K. Kumar, F. Buadi, M. Q. Lacy, D. Dingli, S. Hayman, T. Kourelis, R. Warsame, Y. Hwa, A. Fonder, M. Hobbs, E. Muchtar, N. Leung, P. Kapoor, R. Go, Y. Lin, W. Gonsalves, M. Siddiqui, R. A. Kyle, S. V. Rajkumar, M. A. Gertz, A. Dispenzieri
Format: Article
Language:English
Published: Nature Publishing Group 2023-05-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-023-00859-x
_version_ 1797811965156917248
author I. Vaxman
S. K. Kumar
F. Buadi
M. Q. Lacy
D. Dingli
S. Hayman
T. Kourelis
R. Warsame
Y. Hwa
A. Fonder
M. Hobbs
E. Muchtar
N. Leung
P. Kapoor
R. Go
Y. Lin
W. Gonsalves
M. Siddiqui
R. A. Kyle
S. V. Rajkumar
M. A. Gertz
A. Dispenzieri
author_facet I. Vaxman
S. K. Kumar
F. Buadi
M. Q. Lacy
D. Dingli
S. Hayman
T. Kourelis
R. Warsame
Y. Hwa
A. Fonder
M. Hobbs
E. Muchtar
N. Leung
P. Kapoor
R. Go
Y. Lin
W. Gonsalves
M. Siddiqui
R. A. Kyle
S. V. Rajkumar
M. A. Gertz
A. Dispenzieri
author_sort I. Vaxman
collection DOAJ
first_indexed 2024-03-13T07:30:34Z
format Article
id doaj.art-744df0ab94de46598b60fe543ab0afab
institution Directory Open Access Journal
issn 2044-5385
language English
last_indexed 2024-03-13T07:30:34Z
publishDate 2023-05-01
publisher Nature Publishing Group
record_format Article
series Blood Cancer Journal
spelling doaj.art-744df0ab94de46598b60fe543ab0afab2023-06-04T11:06:55ZengNature Publishing GroupBlood Cancer Journal2044-53852023-05-011311410.1038/s41408-023-00859-xDaratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic ExperienceI. Vaxman0S. K. Kumar1F. Buadi2M. Q. Lacy3D. Dingli4S. Hayman5T. Kourelis6R. Warsame7Y. Hwa8A. Fonder9M. Hobbs10E. Muchtar11N. Leung12P. Kapoor13R. Go14Y. Lin15W. Gonsalves16M. Siddiqui17R. A. Kyle18S. V. Rajkumar19M. A. Gertz20A. Dispenzieri21Division of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo Clinichttps://doi.org/10.1038/s41408-023-00859-x
spellingShingle I. Vaxman
S. K. Kumar
F. Buadi
M. Q. Lacy
D. Dingli
S. Hayman
T. Kourelis
R. Warsame
Y. Hwa
A. Fonder
M. Hobbs
E. Muchtar
N. Leung
P. Kapoor
R. Go
Y. Lin
W. Gonsalves
M. Siddiqui
R. A. Kyle
S. V. Rajkumar
M. A. Gertz
A. Dispenzieri
Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience
Blood Cancer Journal
title Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience
title_full Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience
title_fullStr Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience
title_full_unstemmed Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience
title_short Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience
title_sort daratumumab carfilzomib and pomalidomide for the treatment of poems syndrome the mayo clinic experience
url https://doi.org/10.1038/s41408-023-00859-x
work_keys_str_mv AT ivaxman daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience
AT skkumar daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience
AT fbuadi daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience
AT mqlacy daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience
AT ddingli daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience
AT shayman daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience
AT tkourelis daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience
AT rwarsame daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience
AT yhwa daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience
AT afonder daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience
AT mhobbs daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience
AT emuchtar daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience
AT nleung daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience
AT pkapoor daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience
AT rgo daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience
AT ylin daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience
AT wgonsalves daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience
AT msiddiqui daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience
AT rakyle daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience
AT svrajkumar daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience
AT magertz daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience
AT adispenzieri daratumumabcarfilzomibandpomalidomideforthetreatmentofpoemssyndromethemayoclinicexperience